Eli Lilly Alzheimer's drug approved by US FDA

Eli Lilly Alzheimer's drug approved by US FDA

Source: 
Reuters
snippet: 

The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's (LLY.N) treatment for early Alzheimer's, making it the second therapy for slowing progression of the brain-wasting disease that will be available to U.S. patients.